NASDAQ · DHCReal EstateREITs

Diversified Healthcare Trust Common Shares of Beneficial Interest financials

$7.96−2.09%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
Revenue$1.54B$1.50B$1.41B$1.28B$1.38B$1.63B
Gross profit$1.54B$1.50B$1.41B$1.28B$1.38B$1.63B
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%
Operating income-$205.0M-$125.8M-$103.3M-$93.8M-$13.6M-$12.9M
Net income-$285.9M-$370.3M-$293.6M-$15.8M$174.5M-$139.5M
Net margin−18.6%−24.8%−20.8%−1.2%12.6%−8.5%
Diluted EPS$-1.19$-1.55$-1.23$-0.07$0.73$-0.59
EBITDA$233.0M$232.4M$210.0M$148.1M$250.1M$357.7M
Operating cash flow-$19.6M$112.2M$10.5M-$32.5M-$63.3M$158.5M
Free cash flow-$166.4M-$89.5M-$224.5M-$331.9M-$290.9M-$27.0M
Diluted shares240.3M239.5M238.8M238.3M238.0M237.7M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$105.4M$144.6M$245.9M$658.1M$634.8M$74.4M
Short-term investments$0.00$0.00$0.00$0.00——
Total debt$2.40B$2.93B$2.84B$3.08B$3.71B$3.52B
Total assets$4.36B$5.14B$5.45B$6.00B$6.62B$6.48B
Total liabilities$2.70B$3.18B$3.11B$3.36B$3.96B$3.86B
Shareholders' equity$1.67B$1.96B$2.34B$2.64B$2.66B$2.62B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology